Teladoc Health Inc (NYSE: TDOC) kicked off on November 20, 2023, at the price of $17.12, up 1.75% from the previous trading day. During the day, the shares moved up to $17.725 and dropped to $16.96 before settling in for the closing price of $17.17. Over the past 52 weeks, TDOC has traded in a range of $15.02-$34.36.
During the last 5-year period, the sales growth of Healthcare Sector giant was 62.70%. While this was happening, its average annual earnings per share was recorded 98.36%. With a float of $164.21 million, this company’s outstanding shares have now reached $165.56 million.
Let’s determine the extent of company efficiency that accounts for 5600 employees. In terms of profitability, gross margin is +58.45, operating margin of -9.45, and the pretax margin is -567.69.
Teladoc Health Inc (TDOC) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Teladoc Health Inc is 0.81%, while institutional ownership is 71.65%. The most recent insider transaction that took place on Nov 17, was worth 17,070. In this transaction CHIEF STRATEGY OFFICER of this company sold 1,000 shares at a rate of $17.07, taking the stock ownership to the 19,036 shares. Before that another transaction happened on Nov 02, when Company’s PRESIDENT, ENTERPRISE GROWTH sold 35,887 for $17.05, making the entire transaction worth $611,730. This insider now owns 44,907 shares in total.
Teladoc Health Inc (TDOC) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.35 earnings per share (EPS), higher than consensus estimate (set at -$0.37) by $0.02. This company achieved a net margin of -567.53 while generating a return on equity of -148.85. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 98.36% per share during the next fiscal year.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
Take a look at Teladoc Health Inc’s (TDOC) current performance indicators. Last quarter, stock had a quick ratio of 3.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.12. Likewise, its price to free cash flow for the trailing twelve months is 10.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -24.66, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Teladoc Health Inc (TDOC)
Looking closely at Teladoc Health Inc (NYSE: TDOC), its last 5-days average volume was 4.34 million, which is a drop from its year-to-date volume of 4.6 million. As of the previous 9 days, the stock’s Stochastic %D was 72.93%. Additionally, its Average True Range was 0.80.
During the past 100 days, Teladoc Health Inc’s (TDOC) raw stochastic average was set at 15.92%, which indicates a significant decrease from 79.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.91% in the past 14 days, which was lower than the 58.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.28, while its 200-day Moving Average is $23.55. However, in the short run, Teladoc Health Inc’s stock first resistance to watch stands at $17.81. Second resistance stands at $18.15. The third major resistance level sits at $18.58. If the price goes on to break the first support level at $17.04, it is likely to go to the next support level at $16.62. Now, if the price goes above the second support level, the third support stands at $16.28.
Teladoc Health Inc (NYSE: TDOC) Key Stats
The company with the Market Capitalisation of 2.89 billion has total of 165,557K Shares Outstanding. Its annual sales at the moment are 2,407 M in contrast with the sum of -13,660 M annual income. Company’s last quarter sales were recorded 660,240 K and last quarter income was -57,070 K.